Tacoma Pharmasolutions Profile
Key Indicators
- Authorised Capital ₹ 10.00 K
as on 09-07-2024
- Paid Up Capital ₹ 10.00 K
as on 09-07-2024
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 57057.59%
(FY 2020)
- Profit 110.97%
(FY 2020)
- Ebitda 165.93%
(FY 2020)
- Net Worth 10.99%
(FY 2020)
- Total Assets -92.40%
(FY 2020)
About Tacoma Pharmasolutions
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 K and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Gopalakrishna Bhat, Lauren Hoff, Duane Hadfield, and One other member serve as directors at the Company.
- CIN/LLPIN
U33309MH2018FTC312162
- Company No.
312162
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
24 Jul 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Tacoma Pharmasolutions?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gopalakrishna Bhat  | Director | 26-Mar-2021 | Current |
Lauren Hoff  | Director | 21-Jun-2021 | Current |
| Duane Hadfield | Director | 27-Oct-2020 | Current |
| Joseph Hoff | Director | 24-Jul-2018 | Current |
Financial Performance and Corporate Structure Insights of Tacoma Pharmasolutions.
Tacoma Pharmasolutions Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 57057.59% increase. The company also saw a substantial improvement in profitability, with a 110.97% increase in profit. The company's net worth Soared by an impressive increase of 10.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tacoma Pharmasolutions?
Unlock access to Tacoma Pharmasolutions's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
O9 Solutions Management India Private LimitedActive 14 years 7 monthsGopalakrishna Bhat is a mutual person
Converge Electronics Trading (India) Private LimitedActive 14 years 8 monthsGopalakrishna Bhat is a mutual person
- Convergent Communications (India) Private LimitedActive 26 years 9 days
Gopalakrishna Bhat is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tacoma Pharmasolutions?
Unlock and access historical data on people associated with Tacoma Pharmasolutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tacoma Pharmasolutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tacoma Pharmasolutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
